Childhood obesity Nutritional, Metabolic, Endocrine Obesity
Conditions
Interventions
Participants are randomized to either an experimental group or an active control group (50/50, 30/10 in pilot) via the OPEN CLINICA computer program. The executive function training consists of two ta
Sponsors
Ghent University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Obese youngsters ((a)BMI > 120) 2. Age 8 - 18 3. Both male and female 4. Following treatment (outpatient or inpatient)
Exclusion criteria
Exclusion criteria: Comorbid medical disorders that cause (a part of) the weight gain (i.e. serious thyroid problems)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight index (BMI, adjusted, calibrated) measured at T0-T4 Timepoints: T0 = baseline (at the intake in the treatment centre) T1 = start training (in between there is approximately 4-6 months, depending on the treatment centre) T2 = end of the intensive training (after 6 weeks intensive training and when the follow-up and booster starts) T3 = after 2 months/8 weeks follow up and performing the tasks once a week in booster sessions T4 = after 6 months follow up | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. IQ, measured using Raven Progressive Matrices (task for the participant) at T0-T4, except for the outpatient centers that don’t measure them at T1 2. Depression and anxiety, measured using ASEBA questionnaires: Youth Self Report (YSR) and Child Behavior Checklist (CBCL) and the Children Depression Inventory (CDI) self-report at T0-T4, except for the outpatient centers that don’t measure them at T1 3. Self-worth, measured using CBSA and CBSK, translated version of Self-Perception Profile at T0-T4, except for the outpatient centers that don’t measure them at T1 4. Executive functioning, measured using: 4.1. A questionnaire (Effortful Control Scale (ECS) self-report, BRIEF (Behavior Rating Inventory of Executive Function) = BRIEF-Parent version and BRIEF-teacher version [for the educators at the Zeepreventorium]) at all timepoints, with exclusion of the T1 measurements for the outpatient settings 4.2. Inhibition and attention measurements from the EF tasks (Go-No-Go and Dot Probe Task), errors and reaction times at T0, T1, T2, T3 and T4 5. Eating behaviors, measured using Ch-EDE-Q self-report and Dutch Eating Behavior Questionnaire (“NVE” in Dutch) at T0-T4, except for the outpatient centers that don’t measure them at T1 Added 21/06/2017: Medical variables: 1. Waist and hip measurements at T1 + T3 2. Blood and pulse pressure, measured with automatic meters 3. Puberty status: clinical stages (Tanner) 4. Tonsillar hypertrophy: clinical stages (Brodsky) 5. Blood measurements (venipuncture) 6. Urine (urine sample) 7. Lung function, measured with spirometry and full body plethysmography 8. Vascular function, measured with ENDO-Pat 9. Sleep pattern, measured with ApneaLink and questionnaire 10. Body composition, measured with a Body Composition Monitor (BCM) Timepoints: T0 = baseline (at the intake in the treatment centre) T1 = start training (in between there is approximately 4-6 months, depending on the treatment centre) T2 = end of the intensive training (after 6 w | — |
Countries
Belgium
Outcome results
None listed